Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data von Sarkaria, Jann N, Hu, Leland S, Parney, Ian F, Pafundi, Deanna H, Brinkmann, Debra H, Laack, Nadia N, Giannini, Caterina, Burns, Terence C, Kizilbash, Sani H, Laramy, Janice K, Swanson, Kristin R, Kaufmann, Timothy J, Brown, Paul D, Agar, Nathalie Y R, Galanis, Evanthia, Buckner, Jan C, Elmquist, William F

Volltext

Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine von Kim, Minjee, Kizilbash, Sani H., Laramy, Janice K., Gampa, Gautham, Parrish, Karen E., Sarkaria, Jann N., Elmquist, William F.

Volltext

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity von Gupta, Shiv K, Smith, Emily J, Mladek, Ann C, Tian, Shulan, Decker, Paul A, Kizilbash, Sani H, Kitange, Gaspar J, Sarkaria, Jann N

Volltext

Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma von Kizilbash, Sani H, Gupta, Shiv K, Chang, Kenneth, Kawashima, Ryo, Parrish, Karen E, Carlson, Brett L, Bakken, Katrina K, Mladek, Ann C, Schroeder, Mark A, Decker, Paul A, Kitange, Gaspar J, Shen, Yuqiao, Feng, Ying, Protter, Andrew A, Elmquist, William F, Sarkaria, Jann N

Volltext

Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma von Fortin Ensign, Shannon P, Jenkins, Robert B, Giannini, Caterina, Sarkaria, Jann N, Galanis, Evanthia, Kizilbash, Sani H

Volltext

Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis von Webb, Mason, Johnson, Derek R., Mahajan, Anita, Brown, Paul, Neth, Bryan, Kizilbash, Sani H., Sener, Ugur

Volltext

Discordant In Vitro and In Vivo Chemopotentiating Effects of the PARP Inhibitor Veliparib in Temozolomide-Sensitive versus -Resistant Glioblastoma Multiforme Xenografts von GUPTA, Shiv K, MLADEK, Ann C, CARLSON, Brett L, BOAKYE-AGYEMAN, Felix, BAKKEN, Katrina K, KIZILBASH, Sani H, SCHROEDER, Mark A, REID, Joel, SARKARIA, Jann N

Volltext

Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience von Neth, Bryan J, Raghunathan, Aditya, Kizilbash, Sani H, Uhm, Joon H, Breen, William G, Johnson, Derek R, Daniels, David J, Sener, Ugur, Carabenciov, Ivan D, Campian, Jian L, Khatua, Soumen, Mahajan, Anita, Ruff, Michael W

Volltext

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma von Gupta, Shiv K, Kizilbash, Sani H, Carlson, Brett L, Mladek, Ann C, Boakye-Agyeman, Felix, Bakken, Katrina K, Pokorny, Jenny L, Schroeder, Mark A, Decker, Paul A, Cen, Ling, Eckel-Passow, Jeanette E, Sarkar, Gobinda, Ballman, Karla V, Reid, Joel M, Jenkins, Robert B, Verhaak, Roeland G, Sulman, Erik P, Kitange, Gaspar J, Sarkaria, Jann N

Volltext

Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design von Sener, Ugur, Islam, Mahnoor, Webb, Mason, Kizilbash, Sani H

Volltext

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study von Ramos-Fresnedo, Andres, Pullen, Michael W., Perez-Vega, Carlos, Domingo, Ricardo A., Akinduro, Oluwaseun O., Almeida, Joao P., Suarez-Meade, Paola, Marenco-Hillembrand, Lina, Jentoft, Mark E., Bendok, Bernard R., Trifiletti, Daniel M., Chaichana, Kaisorn L., Porter, Alyx B., Quiñones-Hinojosa, Alfredo, Burns, Terence C., Kizilbash, Sani H., Middlebrooks, Erik H., Sherman, Wendy J.

Volltext

Contemporary Treatment Outcome of Metastases to the Pituitary Gland von Hong, Sukwoo, Atkinson, John L., Erickson, Dana, Kizilbash, Sani H., Little, Jason T., Routman, David M., Van Gompel, Jamie J.

Volltext

Treatment outcome of metastasis to the pituitary gland: a case series of 21 patients with pathological diagnosis von Hong, Sukwoo, Atkinson, John L, Erickson, Dana, Kizilbash, Sani H, Little, Jason T, Routman, David M, Van Gompel, Jamie J

Volltext

Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database von Zreik, Jad, Kerezoudis, Panagiotis, Alvi, Mohammed Ali, Yolcu, Yagiz U., Kizilbash, Sani H.

Volltext

Glioblastoma with bilateral extraocular muscle infiltration preceded by evidence of vascular tropism von Ruff, Michael W., Kizilbash, Sani H.

Volltext

The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database von Kerezoudis, Panagiotis, Goyal, Anshit, Lu, Victor M., Alvi, Mohammed Ali, Bydon, Mohamad, Kizilbash, Sani H., Burns, Terry C.

Volltext

Methodological and analytical considerations for intra-operative microdialysis von Riviere-Cazaux, Cecile, Rajani, Karishma, Rahman, Masum, Oh, Juhee, Brown, Desmond A, White, Jaclyn F, Himes, Benjamin T, Jusue-Torres, Ignacio, Rodriguez, Moses, Warrington, Arthur E, Kizilbash, Sani H, Elmquist, William F, Burns, Terry C

Volltext

Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience von Neth, Bryan J., Balakrishnan, Samantha N., Carabenciov, Ivan D., Uhm, Joon H., Daniels, David J., Kizilbash, Sani H., Ruff, Michael W.

Volltext

In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling von Kizilbash, Sani H., Gupta, Shiv K., Parrish, Karen E., Laramy, Janice K., Kim, Minjee, Gampa, Gautham, Carlson, Brett L., Bakken, Katrina K., Mladek, Ann C., Schroeder, Mark A., Decker, Paul A., Elmquist, William F., Sarkaria, Jann N.

Volltext

Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal von Gupta, Shiv K., Kizilbash, Sani H., Daniels, David J., Sarkaria, Jann N.

Volltext